Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction Of type 2 diabetes

被引:103
作者
Brantsma, AH
Bakker, SJL
Hillege, HL
De Zeeuw, D
De Jong, PE
Gansevoort, RT
机构
[1] Univ Groningen, Med Ctr, Dept Med, Div Nephrol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Med, Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Dept Cardiol, Trial Coordinat Ctr, Groningen, Netherlands
[4] Univ Groningen, Med Ctr, Dept Clin Pharmacol, Groningen, Netherlands
关键词
D O I
10.2337/diacare.28.10.2525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To investigate urinary albumin excretion (UAE) and its relation with C-reactive protein (CRP) and the metabolic syndrome in the prediction of the development of type 2 diabetes. RESEARCH DESIGN AND METHODS - We used data from the Prevention of Renal and Vascular End Stage Disease (PREVEND) study, an ongoing, community-based, prospective cohort study initiated in 1997 in the Netherlands. The initial cohort consisted of 8,592 subjects. After 4 years, 6,894 subjects participated in a follow-up survey. Subjects with diabetes at baseline or missing data on fasting glucose were excluded, leaving 5,654 subjects for analysis. The development of type 2 diabetes, defined as a fasting glucose >= 7.0 mmol/l and/or the use of antidiabetic medication, was used as the outcome measure. UAE was calculated as the mean UAE from two consecutive 24-h urine collections. Logistic regression models were used, with the development of type 2 diabetes as the dependent variable. RESULTS - Of the 5,654 subjects for whom data were analyzed, 185 (3.3%) developed type 2 diabetes during a mean follow-up period of 4.2 years. UAE, CRP, and the presence of the metabolic syndrome at baseline were significantly associated with the incidence of type 2 diabetes (P < 0.001 for all variables). In a univariate model, the odds ratio (OR) for UAE was 1.59 (95% CI 1.42-1.79). In our full model, adjusted for age, sex, number of criteria of metabolic syndrome, and other known risk factors for the development of type 2 diabetes (including fasting insulin), the association between UAE and type 2 diabetes remained significant (OR 1.53,95% CI 1.25-1.88, P < 0.001). There was a significant interaction between UAE and CRP (P = 0.002). After CRP was stratified into tertiles, the ORs for the association between baseline UAE and the development of type 2 diabetes were 2.2 (1.47-3.3), 1.33 (0.96-1.84), and 1.04 (0.83-1.31) for the lowest to highest tertiles, respectively. CONCLUSIONS - UAE predicts type 2 diabetes independent of the metabolic syndrome and other known risk markers of development of type 2 diabetes. The predictive value of UAE was modified by the level of CRP.
引用
收藏
页码:2525 / 2530
页数:6
相关论文
共 36 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   High-sensitivity C-reactive protein: Clinical importance [J].
Bassuk, SS ;
Rifai, N ;
Ridker, PM .
CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) :439-493
[4]   Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications [J].
Bianchi, S ;
Bigazzi, R ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :973-995
[5]   Pancreatic beta-cell loss and preservation in type 2 diabetes [J].
Buchanan, TA .
CLINICAL THERAPEUTICS, 2003, 25 :B32-B46
[6]  
Burnett RW, 2001, CLIN CHIM ACTA, V307, P205
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[9]   DIRECT HEMODYNAMIC-EFFECT OF INSULIN IN THE ISOLATED PERFUSED KIDNEY [J].
COHEN, AJ ;
MCCARTHY, DM ;
STOFF, JS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04) :F580-F585
[10]   MICROALBUMINURIA IN ELDERLY HYPERGLYCEMIC PATIENTS AND CONTROLS [J].
DAMSGAARD, EM ;
MOGENSEN, CE .
DIABETIC MEDICINE, 1986, 3 (05) :430-435